NovoCure
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NovoCure and other ETFs, options, and stocks.About NVCR
NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division.
NVCR Key Statistics
Stock Snapshot
As of today, NovoCure(NVCR) shares are valued at $12.62. The company's market cap stands at 1.43B, with a P/E ratio of -10.43.
During the trading session on 2026-03-11, NovoCure(NVCR) shares reached a daily high of $12.74 and a low of $12.23. At a current price of $12.62, the stock is +3.2% higher than the low and still -0.9% under the high.
Trading activity shows a volume of 911.99K, compared to an average daily volume of 2.79M.
Over the past 52 weeks, NovoCure(NVCR) stock has traded between a high of $21.55 and a low of $9.82.
Over the past 52 weeks, NovoCure(NVCR) stock has traded between a high of $21.55 and a low of $9.82.
NVCR News
In trading on Thursday, shares of NovoCure Ltd (Symbol: NVCR) crossed above their 200 day moving average of $13.70, changing hands as high as $14.33 per share....
Advertisement Japan reimbursement approval reshapes Optune Lua access NovoCure (NVCR) just received reimbursement approval in Japan for its Optune Lua device...
Analyst ratings
75%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.